Article Figures & Data
Figures
- Figure 1.
Radiological response to interferon-alpha (IFNα) at each time point. Overall, 71% of patients had at least 3 months of stable disease (SD) or partial response (PR). CR: Complete response; PD: progressive disease.
- Figure 2.
Kaplan–Meier plot of progression-free survival (PFS) for patients on interferon-alpha (IFNα) monotherapy or with a stable dose of somatostatin analogue prior to IFNα therapy, for all tumor types (N=16), and midgut (N=9) and pancreatic (N=5) tumours. The survival of patients in the midgut and pancreatic subgroups were not significantly different (p=0.657, log-rank test).
- Figure 3.
Toxicities to interferon-alpha graded according to the Common Terminology Criteria for Adverse Events Version 4.0. Grade 1: Mild; grade 2: moderate; grade 3: severe; grade 4: life-threatening. There were no grade 4 toxicities.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.